Advances in the molecular mechanism and diagnosis and treatment of fragile X syndrome
10.3760/cma.j.issn.1008-1372.2018.07.004
- VernacularTitle:脆性X综合征分子机制与诊治进展
- Author:
Cailing XU
1
;
Fang YANG
Author Information
1. 南方医科大学南方医院产前诊断中心
- Keywords:
Fragile X syndrome/GE/DI/TH;
Fragile X mental retardation protein/GE;
Prenatal diagnosis
- From:
Journal of Chinese Physician
2018;20(7):973-975
- CountryChina
- Language:Chinese
-
Abstract:
Fragile X syndrome (FXS) is the most common monogenic disease that causes intellectual disability and autism spectrum disorder (ASD),causing moderate to severe mental retardation with unusual facial features and connective tissue abnormalities.Fragile X syndrome is caused by the mutation of FMR1 gene,resulting in the reduction or loss of its product,fragile X mental retardation protein (FMRP).The diagnosis is mainly based on the detection of FMR1 gene,and there is no effective treatment for fragile X syndrome.Therefore,it is very important to strengthen genetic counseling and prenatal diagnosis,and effectively reduce the incidence of fragile X syndrome.